Three numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
the abstract, start to end
… statins lowered LDL cholesterol by 0.92 mmol/L (95% CI 0.18-1.67) at 1-year of follow-up, increased bodyweight by 0.24 kg (95% CI 0.10-0.38 in all trials; 0.33 kg, 95% CI 0.24-0.42 in placebo or standard care controlled trials and -0.15 kg, 95% CI -0.39 to 0.08 in intensive-dose vs moderate-dose trials) at a mean of 4.2 years (range 1.9-6.7) of follow-up, and increased the odds of new-onset type 2 diabetes (OR 1.12, 95% CI 1.06-1.18 in all …
← favours treatmentfavours comparator →
could be chanceLipids
−0.92−1.67 to −0.18
Lipids
0.240.10–0.38
Lipids
OR 1.121.06–1.18
StatinsLipids
Statins × lipidshelps?mixed
unlikelylikely
0.50not counted
← favours treatmentfavours comparator →
1 / 5